NeoGenomics, Inc. (NGNM.OB)
()
 
 

Overview

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.


Contact Information

12701 Common Wealth Drive
Suite 9
Fort Myers, FL 33913

tel: 239-768-0600
fax: 239-768-0711
http://www.neogenomics.org

,  



Investor Relations



tel:
fax:




Stock

Exchange: OTCBB
Industry: Medical Laboratories & Research
Market Cap: $31.3M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.